Using common features of viruses and EVs for a novel EV-based lateral flow test for HIV
The similarities between extracellular vesicles (EVs) and viruses make them challenging to distinguish and separate into unique populations. A novel lateral flow test has been developed by utilizing these shared properties to improve at-home testing for HIV. By targeting EVs released from HIV infected cells (HIV-EVs) and HIV virus particles for immunocapture, which share common transmembrane proteins like tetraspanins, HIV proteins can be concentrated from blood samples in a lateral flow device. Others have described immunocapture of EVs by lateral flow; here we describe capture and lysis for downstream detection of specific HIV cargo for a sensitive antigen-only HIV test. We found that HIV antigens p24 and Nef are detected early in infection and may significantly improve the sensitivity of an at-home test format by utilizing EVs as a novel reservoir of HIV antigens.
Authors
- Gary Baisa
- Kimberly Luke (ORCID: https://orcid.org/0000-0002-2145-2474)
- Kaitlyn King
- John Hural
- Casey Scott-Weathers
Institutions
- Fred Hutch Cancer Center (US)
- Intuitive Biosciences (United States) (US)
Publication Details
- Journal
- Extracellular Vesicle
- Published
- 2025-06-13
- DOI
- https://doi.org/10.1016/j.vesic.2025.100084
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health